Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jessica Coats"'
Autor:
Jiaxin Niu, Jessica Coats, Lisa Blaydorn, John H. Farley, Cynthia Lynch, Jordan Waypa, Vivek Khemka, Ashish Sangal, Kayla McGahey, Glen J. Weiss
Publikováno v:
British Journal of Cancer
Background: Pembrolizumab (P) is an anti-PD-1 antibody that blocks the interaction between programmed cell death protein 1 (PD-1) on T-cells and PD-L1 and PD-L2 on tumour cells. A phase Ib trial of P plus chemotherapy was undertaken to evaluate the s
Autor:
Jessica Coats, Ashish Sangal, Robert P. Whitehead, Glen J. Weiss, Jordan Waypa, Vivek Khemka, Lisa Blaydorn, Kayla McGahey
Publikováno v:
Cancer Research. 77:CT134-CT134
Background: Pembrolizumab (P) is a checkpoint inhibitor that blocks the interaction between programmed cell death protein 1 on T-cells and PD-L1 and PD-L2 on tumor cells. We conducted a single center phase Ib/II study of gemcitabine, nab-paclitaxel,
Autor:
Jessica Coats, Julia Beck, Kirsten Bornemann-Kolatzki, Jana Bergelin, Tomislav Dragovich, Glen J. Weiss, Ekkehard Schütz, Alexander Koenig, Volker Ellenrieder, William M. Mitchell, Howard B. Urnovitz, Madappa N. Kundranda, Jordan Waypa
Publikováno v:
Journal of Clinical Oncology. 35:e14524-e14524
e14524 Background: Humoral tumor markers are used clinically for real-time assessment of therapeutic efficacy. In pancreatic ductal adenocarcinoma (PDAC) the predominant marker is CA19-9, which is not expressed by 10 to 30% of patients depending on r
Autor:
Angelena Lopez, Jessica Coats, Francisco Canales, Richard W. Carlson, Tracy Cooper, Tahereh Emami
Publikováno v:
Critical Care Medicine. 43:137